Showing results (1371-1380 of 1,963) with videos related to

Sort By:
Pageof 197
Expert Opinion on Drug Discovery|March 21, 2015
Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaAlexandre Monod, Christopher Swale, Bogdan Tarus, et al.
Expert Opinion on Drug Discovery|July 11, 2020
What is on the horizon for type 2 diabetes pharmacotherapy? - An overview of the antidiabetic drug development pipelineKarl Sebastian Johansson, David Peick Sonne, Filip Krag Knop, et al.
Expert Opinion on Drug Discovery|July 11, 2020
Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functionsAndrey D Bondarev, Misty M Attwood, Jörgen Jonsson, et al.
Expert Opinion on Drug Discovery|July 15, 2020
Phage display technology for target determination of small-molecule therapeutics: an updateYoichi Takakusagi, Kaori Takakusagi, Kengo Sakaguchi, et al.
Expert Opinion on Drug Discovery|August 23, 2022
Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressureSophia Konig, Hannah Strobel, Michael Grunert, et al.
Expert Opinion on Drug Discovery|August 15, 2022
Metabolomics in antimicrobial drug discoveryRustam Aminov
Expert Opinion on Drug Discovery|August 19, 2022
Recent advances in cellular models for discovering prion disease therapeuticsLea Nikolić, Chiara Ferracin, Giuseppe Legname
Expert Opinion on Drug Discovery|August 19, 2022
Designing drugs when there is low data availability: one-shot learning and other approaches to face the issues of a long-term concernGabriel C Veríssimo, Mateus Sá M Serafim, Thales Kronenberger, et al.
Expert Opinion on Drug Discovery|August 19, 2022
Role of computational and structural biology in the development of small-molecule modulators of the spliceosomeRiccardo Rozza, Pavel Janoš, Angelo Spinello, et al.
Pageof 197